CML is a unique disease, universally characterized by the presence of BCR-ABL fusion genes, which encodes a constitutively active tyrosine kinase, and is considered responsible for the pathogenesis of CML [15]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.